Shares of Transgenomic, Inc. (NASDAQ:TBIO) Dip Following Announcement of Planned Merger with Precipio

Shares of Transgenomic, Inc. (NASDAQ:TBIO) Dip Following Announcement of Planned Merger with Precipio

Transgenomic, Inc. (NASDAQ:TBIO) announces merger with privately-held Precipio Diagnostics, LLC, pursuant to which Precipio will become a wholly owned subsidiary of Transgenomic, and Transgenomic will be renamed Precipio, Inc. Transgenomic, Inc. (TBIO), and privately-held Precipio Diagnostics, LLC today announced entry into a merger agreement, pursuant to which Precipio will become a wholly owned subsidiary of Transgenomic, and Transgenomic will be renamed Precipio, Inc. In connection with the merger, it is […]

Read More ˃
Shares of Harvest Natural Resources, Inc. (NYSE:HNR) Advance Following Announcement of Sale Of Venezuelan Interests

Shares of Harvest Natural Resources, Inc. (NYSE:HNR) Advance Following Announcement of Sale Of Venezuelan Interests

Independent energy company, Harvest Natural Resources, Inc. (NYSE:HNR), has announced the sale of all of its Venezuelan interests. HOUSTON, Oct. 7, 2016 /PRNewswire/ — Harvest Natural Resources, Inc. (Harvest or the Company) (HNR) has sold all of its Venezuelan interests in a closing that became effective this morning.  The closing occurred in accordance with Harvest’s previously announced share purchase agreement dated June 29, 2016 among Harvest, its subsidiary HNR Energia […]

Read More ˃
Pepsico and Senomyx, Inc. (NASDAQ:SNMX) Announce Three-Year Extension of the “Sweet Taste” Program, How Will the Stock Price Respond?

Pepsico and Senomyx, Inc. (NASDAQ:SNMX) Announce Three-Year Extension of the “Sweet Taste” Program, How Will the Stock Price Respond?

Leading taste science company, Senomyx, Inc. (NASDAQ:SNMX), announces that it has extended its Sweet Taste Program with PepsiCo for another three years. SAN DIEGO, Sept. 30, 2016 /PRNewswire/ — Senomyx, Inc. (SNMX), a leading company using proprietary taste science technologies to discover, develop, and commercialize novel flavor ingredients for the food, beverage, and ingredient supply industries, announced today that it has amended and restated its Sweet Taste Program collaboration agreement […]

Read More ˃
Shares of Ruby Tuesday, Inc. (NYSE:RT) Fall as Q1 Sales Decline, Chain Closes 95 Stores

Shares of Ruby Tuesday, Inc. (NYSE:RT) Fall as Q1 Sales Decline, Chain Closes 95 Stores

Following the release of its Q1 earnings, shares of Ruby Tuesday, Inc. (NYSE:RT) are on the decline. Shares of Ruby Tuesday, Inc. (NYSE: RT) are down following the release of its Q1 earnings after Thursday’s market close. The restaurant operator’s total revenue declined 8.2 percent to $256.7 million, including a net reduction of 109 company-owned Ruby Tuesday restaurants from a year prior. View more earnings on RT Ninety-five restaurants closed […]

Read More ˃
Agria, Corp. (NYSE:GRO) Announces Share Repurchase Plan

Agria, Corp. (NYSE:GRO) Announces Share Repurchase Plan

Global agricultural company, Agria, Corp. (NYSE:GRO), announces that its Board of Directors approved a $10 million share repurchase authorization announced for June 2016. AUCKLAND, NEW ZEALAND–(Marketwired – Oct 6, 2016) – Agria Corporation ( NYSE : GRO ) (the “Company” or “Agria”), a global agricultural company, today announced that its Board of Directors approved a Rule 10b5-1 plan that will implement the $10 million share repurchase authorization announced in June […]

Read More ˃
Idera Pharmaceuticals, Inc. (NASDAQ:IDRA)’s Share Price Dips Following Announcement of $50M Public Offering

Idera Pharmaceuticals, Inc. (NASDAQ:IDRA)’s Share Price Dips Following Announcement of $50M Public Offering

Idera Pharmaceuticals, Inc. (NASDAQ:IDRA) announces offer to sell common stock worth $50 million in an underwritten public offering. Idera Pharmaceuticals Inc. (IDRA) has announced its offer to sell common stock worth $50 million in an underwritten public offering. All the shares in the common stock offering will be sold by Idera, pursuant to a shelf registration statement filed with and declared effective by the Securities and Exchange Commission in 2014. […]

Read More ˃
Shares of Tenax Therapeutics, Inc. (NASDAQ:TENX) Decline Following Update

Shares of Tenax Therapeutics, Inc. (NASDAQ:TENX) Decline Following Update

Specialty pharmaceutical company, Tenax Therapeutics, Inc. (NASDAQ:TENX), today announced a clinical development update for its lead candidate, levosimendan. Tenax Therapeutics, Inc. (TENX), a specialty pharmaceutical company focused on identifying, developing and commercializing products for the critical care market, today reported a comprehensive clinical development update for its lead candidate levosimendan. Tenax announced today that it has enrolled 833 patients in the Phase 3 LEVO-CTS trial in cardiac surgery patients. The […]

Read More ˃
Jefferies & Co Reiterates Biogen Idec Inc. (NASDAQ:BIIB) Hold Rating; Lowers PT to $316 from $323

Jefferies & Co Reiterates Biogen Idec Inc. (NASDAQ:BIIB) Hold Rating; Lowers PT to $316 from $323

In a note to investors, Jefferies & Co reiterated their Hold rating on Biogen Idec Inc. (NASDAQ:BIIB), lowing their price target to $316. Shares of Biogen Idec Inc. (NASDAQ:BIIB) are trading -0.54% at the time of writing and in the range of $308.60 – 313.32 for the current session. Are Shares Ready to Explode? Sign up to our Newsletter to be the First to Know On a consensus level, sell-side […]

Read More ˃
Booz Allen Hamilton Holding Corporation (NYSE:BAH) Employee Arrested on Possible Theft of Classified Source Codes

Booz Allen Hamilton Holding Corporation (NYSE:BAH) Employee Arrested on Possible Theft of Classified Source Codes

Shares of Booz Allen Hamilton (BAH) were lower on Wednesday after the New York Times reported that another employee of the National Security Agency (NSA) contractor has been arrested for a possible “theft of secrets.” The employee has been identified as Harold T. Martin III of Maryland. Martin allegedly stole and disclosed highly classified computer “source codes” designed to hack into the networks of foreign accounts such as Russia and […]

Read More ˃
Analysts Views Strong on Bill Barrett Corporation (BBG)

Analysts Views Strong on Bill Barrett Corporation (BBG)

Several analysts have recently weighed in on Bill Barrett Corporation (NYSE:BBG), issuing notes to investors. Glickman Stewart of S&P Capital IQ Reported on the stock on 12th August with a $6.00 price target, or 14.50% Upside to the last closing price. “The company’s acreage positions in the DJ Basin are primarily located in Colorado’s eastern plains and parts of southeastern Wyoming. As of December 31, 2013, its estimated proved reserves […]

Read More ˃
Analysts Bullish on Cambrex Corporation (NYSE:CBM)

Analysts Bullish on Cambrex Corporation (NYSE:CBM)

Several analysts have recently weighed in on Cambrex Corporation (NYSE:CBM), Dmitry Silversteyn of long Bow Research gives their Buy rating on the stock July 31, 2015 with a $60.00 price target, or 25% upside to the last closing price. Maynard Um of Wells Fargo also released a note to investors yesterday reiterating the firms Hold stance on Blackberry. Raising target price. We are raising our 12-month target price from $48 […]

Read More ˃
Analysts Views Mixed on BBCN Bancorp Inc (NASDAQ:BBCN)

Analysts Views Mixed on BBCN Bancorp Inc (NASDAQ:BBCN)

Several analysts have recently weighed in on BBCN Bancorp Inc (NASDAQ:BBCN), issuing notes to investors. Julianna Balicka of Keefe, Bruyette & Woods released a note on the stock 2 ago with a $16.00 price target. “BBCN is continuing to make progress in its strategy of winning banking business from U.S.-based subsidiaries of South Korean companies. As of June 30, BBCN had $1.15bn of commercial commitments outstanding with a utilization rate […]

Read More ˃
Analysts Views Mixed on Actuant Corporation (NYSE:ATU)

Analysts Views Mixed on Actuant Corporation (NYSE:ATU)

An Analyst has recently weighed in on Actuant Corporation (NYSE:ATU). Matthew McConnell of RBC Capita Outperform with a $26.00 price target or 19.87% upside to the last closing price on October 08, 2015. “Buy – Describes securities that we expect to provide a total return (price appreciation plus yield) of 15% or more within a 12-month period. Hold – Describes securities that we expect to provide a total return (price […]

Read More ˃
Analysts Views Mixed on BioCryst Pharmaceuticals, Inc. (BCRX)

Analysts Views Mixed on BioCryst Pharmaceuticals, Inc. (BCRX)

Several analysts have recently weighed in on BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX), issuing notes to investors. SHAWN M. HARRISON of Longbow Research reiterated their Hold rating on the stock August 2015. “BGC’s new CEO, Michael McDonnell outlined a portion of a new, yet developing, strategic roadmap that includes BGC delivering EBIT margins at an industry leading level of approximately 7%. While Mr. McDonnell has yet to visit all of BGC’s sites, […]

Read More ˃
Here’s Why Topeca Capital Markets Lowered Price Targets on Bonanza Creek Energy Inc (NYSE:BCEI)

Here’s Why Topeca Capital Markets Lowered Price Targets on Bonanza Creek Energy Inc (NYSE:BCEI)

Equity Analyst Gabriele Sorbara of Topeca Capital Markets Issued a report on Bonanza Creek Energy Inc (NYSE:BCEI) titled ”3Q15 Preview; Adjusting Estimates; Reaffirm Buy.” Lowering their price target to $11 from $18. According to the report ”We revisit our estimates for our recently revised commodity price deck (see this morning’s weekly industry report for details) and preview 3Q15 results, expected in early November. We reaffirm our Buy, but recognize it […]

Read More ˃
Why Stephens, Inc., Upgraded Price Target on Pacific Biosciences of California (NASDAQ:PACB) from $7 to $8

Why Stephens, Inc., Upgraded Price Target on Pacific Biosciences of California (NASDAQ:PACB) from $7 to $8

Equity Analysts Drew Jones and associate Garrett Phelps of Stephens, Inc., issued a report on Pacific Biosciences of California (NASDAQ:PACB) titled ”Upgrading to OW/Vol: Improved Technology, Costs Decrease, Roche Relationship” and upgraded their price target from $7 to $8. According to the analysts ”We are upgrading PACB to Overweight/Vol. from Equal-Weight (Vol) given an increasingly favorable outlook for 2016 and beyond. We expect substantial costs reductions for the customer using […]

Read More ˃
MorningStar Updates Star Rating on Continental Resources, Inc.(NYSE:CLR) Here Is Why

MorningStar Updates Star Rating on Continental Resources, Inc.(NYSE:CLR) Here Is Why

Equity Analyst David Meats of Investment Research Firm MorningStar issued a research report called ”Continental has a dominant position in the Williston Basin and is delineating SCOOP in Oklahoma.and Updated their Star Rating on Continental Resources, Inc.(NYSE:CLR). According to the report ”Continental Resources went public in 2007, but the company was established several decades prior by the current CEO and chairman, Harold Hamm. Originally targeting natural gas plays in Oklahoma, […]

Read More ˃
A Look at Why RBC Capital Markets Lowered their Price Target on Flextronics International Ltd.(NASDAQ:FLEX) to $13 from $14.

A Look at Why RBC Capital Markets Lowered their Price Target on Flextronics International Ltd.(NASDAQ:FLEX) to $13 from $14.

On October 4 Equity Analysts Amit Daryanani, CFA, Mitch Steves and Associates Irvin Liu and Jeriel Ong of RBC Capital Markets Equity Research Lowered their Price Target on Flextronics International Ltd.(NASDAQ:FLEX) to $13 from $14. and Issued a report titled ”Adjusting Estimates To Reflect Challenging Macro In H2:15.” According to the report ”We are adjusting our estimates lower on FLEX to reflect multiple headwinds that we think will curtail revenue […]

Read More ˃
The Inside Scoop on Why Deutsche Bank Reiterated their $36 Buy Rating on TerraForm Power Inc(NASDAQ:TERP)

The Inside Scoop on Why Deutsche Bank Reiterated their $36 Buy Rating on TerraForm Power Inc(NASDAQ:TERP)

On October 4 research analyst Vishal Shah and research associate Jerimiah Booream-Phelps Reiterated their $36 Buy Rating on TerraForm Power Inc(NASDAQ:TERP) and issued a report titled ”Takeaways from Management Meeting.” Overall thoughts on the meeting were ”We walked away incrementally more positive after meeting TERP management team. We expect concerns over near term capital raise to fade over the next few months as the company executes on closing the VSLR […]

Read More ˃
Oppenheimer Initiates Buy Rating on Rockwell Medical Inc (NASDAQ:RMTI)

Oppenheimer Initiates Buy Rating on Rockwell Medical Inc (NASDAQ:RMTI)

Equity Analyst Ling Wang, CFA of Investment Research Firm Oppenheimer issued a research report and ”outperform” rating on Rockwell Medical Inc (NASDAQ:RMTI) titled ”Management Update—Buying On Weakness/Reiterate Outperform & $26 PT” on September 28 with a $26 12 to 18 month price target. Ling Wang, CFA stated ”RMTI shares have declined significantly (down ~25% YTD) along with the highly volatile biotechnology market. With the stock trading even below the level […]

Read More ˃